author-photo

Christa Krupski

Cincinnati Children's Hospital Medical Center

15

Papers

95

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Optimal fludarabine lymphodepletion is associated with improved outcomes following CAR T-cell Therapy.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Tisagenlecleucel Outcomes in Relapsed/Refractory Extramedullary ALL: A Pediatric Real World CAR Consortium Report.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities

2020 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (11)
Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.

2020 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Real-World Treatment of Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Using Tisagenlecleucel That Is out of Specification for Commercial Release

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (5)
Allogeneic Hematopoietic Stem Cell Transplant Outcomes for Patients with Dominant-Negative IKFZ1/IKAROS Mutations

2019 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (12)